Global Blood Plasma Derivatives Market Research Report 2020

Global Blood Plasma Derivatives Market Research Report 2020

Table of Contents
1 Blood Plasma Derivatives Market Overview
1.1 Product Overview and Scope of Blood Plasma Derivatives
1.2 Blood Plasma Derivatives Segment by Type
1.2.1 Global Blood Plasma Derivatives Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Albumin
1.2.3 Factor VIII
1.2.4 Factor IX
1.2.5 Immunoglobulin
1.2.6 Hyperimmune Globulin
1.2.7 Others
1.3 Blood Plasma Derivatives Segment by Application
1.3.1 Blood Plasma Derivatives Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other End Users
1.4 Global Blood Plasma Derivatives Market Size Estimates and Forecasts
1.4.1 Global Blood Plasma Derivatives Revenue 2015-2026
1.4.2 Global Blood Plasma Derivatives Sales 2015-2026
1.4.3 Blood Plasma Derivatives Market Size by Region: 2020 Versus 2026
2 Global Blood Plasma Derivatives Market Competition by Manufacturers
2.1 Global Blood Plasma Derivatives Sales Market Share by Manufacturers (2015-2020)
2.2 Global Blood Plasma Derivatives Revenue Share by Manufacturers (2015-2020)
2.3 Global Blood Plasma Derivatives Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Blood Plasma Derivatives Manufacturing Sites, Area Served, Product Type
2.5 Blood Plasma Derivatives Market Competitive Situation and Trends
2.5.1 Blood Plasma Derivatives Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Blood Plasma Derivatives Players (Opinion Leaders)
3 Blood Plasma Derivatives Retrospective Market Scenario by Region
3.1 Global Blood Plasma Derivatives Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Blood Plasma Derivatives Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Blood Plasma Derivatives Market Facts & Figures by Country
3.3.1 North America Blood Plasma Derivatives Sales by Country
3.3.2 North America Blood Plasma Derivatives Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Blood Plasma Derivatives Market Facts & Figures by Country
3.4.1 Europe Blood Plasma Derivatives Sales by Country
3.4.2 Europe Blood Plasma Derivatives Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Blood Plasma Derivatives Market Facts & Figures by Region
3.5.1 Asia Pacific Blood Plasma Derivatives Sales by Region
3.5.2 Asia Pacific Blood Plasma Derivatives Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Blood Plasma Derivatives Market Facts & Figures by Country
3.6.1 Latin America Blood Plasma Derivatives Sales by Country
3.6.2 Latin America Blood Plasma Derivatives Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Blood Plasma Derivatives Market Facts & Figures by Country
3.7.1 Middle East and Africa Blood Plasma Derivatives Sales by Country
3.7.2 Middle East and Africa Blood Plasma Derivatives Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Blood Plasma Derivatives Historic Market Analysis by Type
4.1 Global Blood Plasma Derivatives Sales Market Share by Type (2015-2020)
4.2 Global Blood Plasma Derivatives Revenue Market Share by Type (2015-2020)
4.3 Global Blood Plasma Derivatives Price Market Share by Type (2015-2020)
4.4 Global Blood Plasma Derivatives Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Blood Plasma Derivatives Historic Market Analysis by Application
5.1 Global Blood Plasma Derivatives Sales Market Share by Application (2015-2020)
5.2 Global Blood Plasma Derivatives Revenue Market Share by Application (2015-2020)
5.3 Global Blood Plasma Derivatives Price by Application (2015-2020)
6 Company Profiles and Key Figures in Blood Plasma Derivatives Business
6.1 Grifols
6.1.1 Corporation Information
6.1.2 Grifols Description, Business Overview and Total Revenue
6.1.3 Grifols Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Grifols Products Offered
6.1.5 Grifols Recent Development
6.2 SK Plasma
6.2.1 SK Plasma Blood Plasma Derivatives Production Sites and Area Served
6.2.2 SK Plasma Description, Business Overview and Total Revenue
6.2.3 SK Plasma Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
6.2.4 SK Plasma Products Offered
6.2.5 SK Plasma Recent Development
6.3 Fusion Health Care
6.3.1 Fusion Health Care Blood Plasma Derivatives Production Sites and Area Served
6.3.2 Fusion Health Care Description, Business Overview and Total Revenue
6.3.3 Fusion Health Care Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Fusion Health Care Products Offered
6.3.5 Fusion Health Care Recent Development
6.4 Biotest AG
6.4.1 Biotest AG Blood Plasma Derivatives Production Sites and Area Served
6.4.2 Biotest AG Description, Business Overview and Total Revenue
6.4.3 Biotest AG Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Biotest AG Products Offered
6.4.5 Biotest AG Recent Development
6.5 Green Cross Corporation
6.5.1 Green Cross Corporation Blood Plasma Derivatives Production Sites and Area Served
6.5.2 Green Cross Corporation Description, Business Overview and Total Revenue
6.5.3 Green Cross Corporation Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Green Cross Corporation Products Offered
6.5.5 Green Cross Corporation Recent Development
6.6 Baxter International
6.6.1 Baxter International Blood Plasma Derivatives Production Sites and Area Served
6.6.2 Baxter International Description, Business Overview and Total Revenue
6.6.3 Baxter International Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Baxter International Products Offered
6.6.5 Baxter International Recent Development
6.7 LFB
6.6.1 LFB Blood Plasma Derivatives Production Sites and Area Served
6.6.2 LFB Description, Business Overview and Total Revenue
6.6.3 LFB Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
6.4.4 LFB Products Offered
6.7.5 LFB Recent Development
6.8 Octapharma AG
6.8.1 Octapharma AG Blood Plasma Derivatives Production Sites and Area Served
6.8.2 Octapharma AG Description, Business Overview and Total Revenue
6.8.3 Octapharma AG Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Octapharma AG Products Offered
6.8.5 Octapharma AG Recent Development
6.9 CSL Limited
6.9.1 CSL Limited Blood Plasma Derivatives Production Sites and Area Served
6.9.2 CSL Limited Description, Business Overview and Total Revenue
6.9.3 CSL Limited Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
6.9.4 CSL Limited Products Offered
6.9.5 CSL Limited Recent Development
6.10 Takeda
6.10.1 Takeda Blood Plasma Derivatives Production Sites and Area Served
6.10.2 Takeda Description, Business Overview and Total Revenue
6.10.3 Takeda Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Takeda Products Offered
6.10.5 Takeda Recent Development
6.11 China Biologic Products
6.11.1 China Biologic Products Blood Plasma Derivatives Production Sites and Area Served
6.11.2 China Biologic Products Blood Plasma Derivatives Description, Business Overview and Total Revenue
6.11.3 China Biologic Products Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
6.11.4 China Biologic Products Products Offered
6.11.5 China Biologic Products Recent Development
6.12 Kedrion Biopharma
6.12.1 Kedrion Biopharma Blood Plasma Derivatives Production Sites and Area Served
6.12.2 Kedrion Biopharma Blood Plasma Derivatives Description, Business Overview and Total Revenue
6.12.3 Kedrion Biopharma Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Kedrion Biopharma Products Offered
6.12.5 Kedrion Biopharma Recent Development
6.13 BDI Pharma
6.13.1 BDI Pharma Blood Plasma Derivatives Production Sites and Area Served
6.13.2 BDI Pharma Blood Plasma Derivatives Description, Business Overview and Total Revenue
6.13.3 BDI Pharma Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
6.13.4 BDI Pharma Products Offered
6.13.5 BDI Pharma Recent Development
6.14 Bayer AG
6.14.1 Bayer AG Blood Plasma Derivatives Production Sites and Area Served
6.14.2 Bayer AG Blood Plasma Derivatives Description, Business Overview and Total Revenue
6.14.3 Bayer AG Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Bayer AG Products Offered
6.14.5 Bayer AG Recent Development
6.15 Hualan Biological Engineering
6.15.1 Hualan Biological Engineering Blood Plasma Derivatives Production Sites and Area Served
6.15.2 Hualan Biological Engineering Blood Plasma Derivatives Description, Business Overview and Total Revenue
6.15.3 Hualan Biological Engineering Blood Plasma Derivatives Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Hualan Biological Engineering Products Offered
6.15.5 Hualan Biological Engineering Recent Development
7 Blood Plasma Derivatives Manufacturing Cost Analysis
7.1 Blood Plasma Derivatives Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Blood Plasma Derivatives
7.4 Blood Plasma Derivatives Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Blood Plasma Derivatives Distributors List
8.3 Blood Plasma Derivatives Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Blood Plasma Derivatives Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Blood Plasma Derivatives by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Blood Plasma Derivatives by Type (2021-2026)
10.2 Blood Plasma Derivatives Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Blood Plasma Derivatives by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Blood Plasma Derivatives by Application (2021-2026)
10.3 Blood Plasma Derivatives Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Blood Plasma Derivatives by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Blood Plasma Derivatives by Region (2021-2026)
10.4 North America Blood Plasma Derivatives Estimates and Projections (2021-2026)
10.5 Europe Blood Plasma Derivatives Estimates and Projections (2021-2026)
10.6 Asia Pacific Blood Plasma Derivatives Estimates and Projections (2021-2026)
10.7 Latin America Blood Plasma Derivatives Estimates and Projections (2021-2026)
10.8 Middle East and Africa Blood Plasma Derivatives Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Blood Plasma Derivatives Sales (K MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Blood Plasma Derivatives Sales (K MT) Comparison by Application: 2020 VS 2026
Table 3. Global Blood Plasma Derivatives Market Size by Type (K MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Blood Plasma Derivatives Manufacturers Covered in This Study
Table 5. Global Blood Plasma Derivatives Sales (K MT) by Manufacturers (2015-2020)
Table 6. Global Blood Plasma Derivatives Sales Share by Manufacturers (2015-2020)
Table 7. Global Blood Plasma Derivatives Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Blood Plasma Derivatives Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Blood Plasma Derivatives Average Price (USD/MT) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Blood Plasma Derivatives Sales Sites and Area Served
Table 11. Manufacturers Blood Plasma Derivatives Product Types
Table 12. Global Blood Plasma Derivatives Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Blood Plasma Derivatives by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blood Plasma Derivatives as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Blood Plasma Derivatives Players
Table 16. Global Blood Plasma Derivatives Sales (K MT) by Region (2015-2020)
Table 17. Global Blood Plasma Derivatives Sales Market Share by Region (2015-2020)
Table 18. Global Blood Plasma Derivatives Revenue (Million US$) by Region (2015-2020)
Table 19. Global Blood Plasma Derivatives Revenue Market Share by Region (2015-2020)
Table 20. North America Blood Plasma Derivatives Sales by Country (2015-2020) (K MT)
Table 21. North America Blood Plasma Derivatives Sales Market Share by Country (2015-2020)
Table 22. North America Blood Plasma Derivatives Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Blood Plasma Derivatives Revenue Market Share by Country (2015-2020)
Table 24. Europe Blood Plasma Derivatives Sales by Country (2015-2020) (K MT)
Table 25. Europe Blood Plasma Derivatives Sales Market Share by Country (2015-2020)
Table 26. Europe Blood Plasma Derivatives Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Blood Plasma Derivatives Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Blood Plasma Derivatives Sales by Region (2015-2020) (K MT)
Table 29. Asia Pacific Blood Plasma Derivatives Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Blood Plasma Derivatives Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Blood Plasma Derivatives Revenue Market Share by Region (2015-2020)
Table 32. Latin America Blood Plasma Derivatives Sales by Country (2015-2020) (K MT)
Table 33. Latin America Blood Plasma Derivatives Sales Market Share by Country (2015-2020)
Table 34. Latin America Blood Plasma Derivatives Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Blood Plasma Derivatives Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Blood Plasma Derivatives Sales by Country (2015-2020) (K MT)
Table 37. Middle East and Africa Blood Plasma Derivatives Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Blood Plasma Derivatives Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Blood Plasma Derivatives Revenue Market Share by Country (2015-2020)
Table 40. Global Blood Plasma Derivatives Sales (K MT) by Type (2015-2020)
Table 41. Global Blood Plasma Derivatives Sales Share by Type (2015-2020)
Table 42. Global Blood Plasma Derivatives Revenue (Million US$) by Type (2015-2020)
Table 43. Global Blood Plasma Derivatives Revenue Share by Type (2015-2020)
Table 44. Global Blood Plasma Derivatives Price (USD/MT) by Type (2015-2020)
Table 45. Global Blood Plasma Derivatives Sales (K MT) by Application (2015-2020)
Table 46. Global Blood Plasma Derivatives Sales Market Share by Application (2015-2020)
Table 47. Global Blood Plasma Derivatives Sales Growth Rate by Application (2015-2020)
Table 48. Grifols Blood Plasma Derivatives Corporation Information
Table 49. Grifols Description and Business Overview
Table 50. Grifols Blood Plasma Derivatives Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 51. Grifols Main Product
Table 52. Grifols Recent Development
Table 53. SK Plasma Blood Plasma Derivatives Corporation Information
Table 54. SK Plasma Corporation Information
Table 55. SK Plasma Blood Plasma Derivatives Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 56. SK Plasma Main Product
Table 57. SK Plasma Recent Development
Table 58. Fusion Health Care Blood Plasma Derivatives Corporation Information
Table 59. Fusion Health Care Corporation Information
Table 60. Fusion Health Care Blood Plasma Derivatives Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 61. Fusion Health Care Main Product
Table 62. Fusion Health Care Recent Development
Table 63. Biotest AG Blood Plasma Derivatives Corporation Information
Table 64. Biotest AG Corporation Information
Table 65. Biotest AG Blood Plasma Derivatives Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 66. Biotest AG Main Product
Table 67. Biotest AG Recent Development
Table 68. Green Cross Corporation Blood Plasma Derivatives Corporation Information
Table 69. Green Cross Corporation Corporation Information
Table 70. Green Cross Corporation Blood Plasma Derivatives Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 71. Green Cross Corporation Main Product
Table 72. Green Cross Corporation Recent Development
Table 73. Baxter International Blood Plasma Derivatives Corporation Information
Table 74. Baxter International Corporation Information
Table 75. Baxter International Blood Plasma Derivatives Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 76. Baxter International Main Product
Table 77. Baxter International Recent Development
Table 78. LFB Blood Plasma Derivatives Corporation Information
Table 79. LFB Corporation Information
Table 80. LFB Blood Plasma Derivatives Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. LFB Main Product
Table 82. LFB Recent Development
Table 83. Octapharma AG Blood Plasma Derivatives Corporation Information
Table 84. Octapharma AG Corporation Information
Table 85. Octapharma AG Blood Plasma Derivatives Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. Octapharma AG Main Product
Table 87. Octapharma AG Recent Development
Table 88. CSL Limited Blood Plasma Derivatives Corporation Information
Table 89. CSL Limited Corporation Information
Table 90. CSL Limited Blood Plasma Derivatives Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. CSL Limited Main Product
Table 92. CSL Limited Recent Development
Table 93. Takeda Blood Plasma Derivatives Corporation Information
Table 94. Takeda Corporation Information
Table 95. Takeda Blood Plasma Derivatives Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 96. Takeda Main Product
Table 97. Takeda Recent Development
Table 98. China Biologic Products Blood Plasma Derivatives Corporation Information
Table 99. China Biologic Products Corporation Information
Table 100. China Biologic Products Blood Plasma Derivatives Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 101. China Biologic Products Main Product
Table 102. China Biologic Products Recent Development
Table 103. Kedrion Biopharma Blood Plasma Derivatives Corporation Information
Table 104. Kedrion Biopharma Corporation Information
Table 105. Kedrion Biopharma Blood Plasma Derivatives Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 106. Kedrion Biopharma Main Product
Table 107. Kedrion Biopharma Recent Development
Table 108. BDI Pharma Blood Plasma Derivatives Corporation Information
Table 109. BDI Pharma Corporation Information
Table 110. BDI Pharma Blood Plasma Derivatives Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 111. BDI Pharma Main Product
Table 112. BDI Pharma Recent Development
Table 113. Bayer AG Blood Plasma Derivatives Corporation Information
Table 114. Bayer AG Corporation Information
Table 115. Bayer AG Blood Plasma Derivatives Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 116. Bayer AG Main Product
Table 117. Bayer AG Recent Development
Table 118. Hualan Biological Engineering Blood Plasma Derivatives Corporation Information
Table 119. Hualan Biological Engineering Corporation Information
Table 120. Hualan Biological Engineering Blood Plasma Derivatives Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 121. Hualan Biological Engineering Main Product
Table 122. Hualan Biological Engineering Recent Development
Table 123. Sales Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Blood Plasma Derivatives Distributors List
Table 126. Blood Plasma Derivatives Customers List
Table 127. Market Key Trends
Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 129. Key Challenges
Table 130. Global Blood Plasma Derivatives Sales (K MT) Forecast by Type (2021-2026)
Table 131. Global Blood Plasma Derivatives Sales Market Share Forecast by Type (2021-2026)
Table 132. Global Blood Plasma Derivatives Revenue (Million US$) Forecast by Type (2021-2026)
Table 133. Global Blood Plasma Derivatives Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 134. Global Blood Plasma Derivatives Sales (K MT) Forecast by Application (2021-2026)
Table 135. Global Blood Plasma Derivatives Revenue (Million US$) Forecast by Application (2021-2026)
Table 136. Global Blood Plasma Derivatives Sales (K MT) Forecast by Region (2021-2026)
Table 137. Global Blood Plasma Derivatives Sales Market Share Forecast by Region (2021-2026)
Table 138. Global Blood Plasma Derivatives Revenue Forecast by Region (2021-2026) (US$ Million)
Table 139. Global Blood Plasma Derivatives Revenue Market Share Forecast by Region (2021-2026)
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Blood Plasma Derivatives
Figure 2. Global Blood Plasma Derivatives Sales Market Share by Type: 2020 VS 2026
Figure 3. Albumin Product Picture
Figure 4. Factor VIII Product Picture
Figure 5. Factor IX Product Picture
Figure 6. Immunoglobulin Product Picture
Figure 7. Hyperimmune Globulin Product Picture
Figure 8. Others Product Picture
Figure 9. Global Blood Plasma Derivatives Consumption Market Share by Application: 2020 VS 2026
Figure 10. Hospitals
Figure 11. Clinics
Figure 12. Other End Users
Figure 13. Global Blood Plasma Derivatives Market Size 2015-2026 (US$ Million)
Figure 14. Global Blood Plasma Derivatives Sales Capacity (K MT) (2015-2026)
Figure 15. Global Blood Plasma Derivatives Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Blood Plasma Derivatives Sales Share by Manufacturers in 2020
Figure 17. Global Blood Plasma Derivatives Revenue Share by Manufacturers in 2019
Figure 18. The Global 5 and 10 Largest Players: Market Share by Blood Plasma Derivatives Revenue in 2019
Figure 19. Blood Plasma Derivatives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Blood Plasma Derivatives Sales Market Share by Region (2015-2020)
Figure 21. Global Blood Plasma Derivatives Sales Market Share by Region in 2019
Figure 22. Global Blood Plasma Derivatives Revenue Market Share by Region (2015-2020)
Figure 23. Global Blood Plasma Derivatives Revenue Market Share by Region in 2019
Figure 24. North America Blood Plasma Derivatives Sales Market Share by Country in 2019
Figure 25. North America Blood Plasma Derivatives Revenue Market Share by Country in 2019
Figure 26. U.S. Blood Plasma Derivatives Sales Growth Rate (2015-2020) (K MT)
Figure 27. U.S. Blood Plasma Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Canada Blood Plasma Derivatives Sales Growth Rate (2015-2020) (K MT)
Figure 29. Canada Blood Plasma Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. Europe Blood Plasma Derivatives Sales Market Share by Country in 2019
Figure 31. Europe Blood Plasma Derivatives Revenue Market Share by Country in 2019
Figure 32. Germany Blood Plasma Derivatives Sales Growth Rate (2015-2020) (K MT)
Figure 33. Germany Blood Plasma Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. France Blood Plasma Derivatives Sales Growth Rate (2015-2020) (K MT)
Figure 35. France Blood Plasma Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. U.K. Blood Plasma Derivatives Sales Growth Rate (2015-2020) (K MT)
Figure 37. U.K. Blood Plasma Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Italy Blood Plasma Derivatives Sales Growth Rate (2015-2020) (K MT)
Figure 39. Italy Blood Plasma Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Russia Blood Plasma Derivatives Sales Growth Rate (2015-2020) (K MT)
Figure 41. Russia Blood Plasma Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Asia Pacific Blood Plasma Derivatives Sales Market Share by Region in 2019
Figure 43. Asia Pacific Blood Plasma Derivatives Revenue Market Share by Region in 2019
Figure 44. China Blood Plasma Derivatives Sales Growth Rate (2015-2020) (K MT)
Figure 45. China Blood Plasma Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Japan Blood Plasma Derivatives Sales Growth Rate (2015-2020) (K MT)
Figure 47. Japan Blood Plasma Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. South Korea Blood Plasma Derivatives Sales Growth Rate (2015-2020) (K MT)
Figure 49. South Korea Blood Plasma Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. India Blood Plasma Derivatives Sales Growth Rate (2015-2020) (K MT)
Figure 51. India Blood Plasma Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Australia Blood Plasma Derivatives Sales Growth Rate (2015-2020) (K MT)
Figure 53. Australia Blood Plasma Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Taiwan Blood Plasma Derivatives Sales Growth Rate (2015-2020) (K MT)
Figure 55. Taiwan Blood Plasma Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Indonesia Blood Plasma Derivatives Sales Growth Rate (2015-2020) (K MT)
Figure 57. Indonesia Blood Plasma Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Thailand Blood Plasma Derivatives Sales Growth Rate (2015-2020) (K MT)
Figure 59. Thailand Blood Plasma Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Malaysia Blood Plasma Derivatives Sales Growth Rate (2015-2020) (K MT)
Figure 61. Malaysia Blood Plasma Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Philippines Blood Plasma Derivatives Sales Growth Rate (2015-2020) (K MT)
Figure 63. Philippines Blood Plasma Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Vietnam Blood Plasma Derivatives Sales Growth Rate (2015-2020) (K MT)
Figure 65. Vietnam Blood Plasma Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Latin America Blood Plasma Derivatives Sales Market Share by Country in 2019
Figure 67. Latin America Blood Plasma Derivatives Revenue Market Share by Country in 2019
Figure 68. Mexico Blood Plasma Derivatives Sales Growth Rate (2015-2020) (K MT)
Figure 69. Mexico Blood Plasma Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Brazil Blood Plasma Derivatives Sales Growth Rate (2015-2020) (K MT)
Figure 71. Brazil Blood Plasma Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Argentina Blood Plasma Derivatives Sales Growth Rate (2015-2020) (K MT)
Figure 73. Argentina Blood Plasma Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Middle East and Africa Blood Plasma Derivatives Sales Market Share by Country in 2019
Figure 75. Middle East and Africa Blood Plasma Derivatives Revenue Market Share by Country in 2019
Figure 76. Turkey Blood Plasma Derivatives Sales Growth Rate (2015-2020) (K MT)
Figure 77. Turkey Blood Plasma Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Saudi Arabia Blood Plasma Derivatives Sales Growth Rate (2015-2020) (K MT)
Figure 79. Saudi Arabia Blood Plasma Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. U.A.E Blood Plasma Derivatives Sales Growth Rate (2015-2020) (K MT)
Figure 81. U.A.E Blood Plasma Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Sales Market Share of Blood Plasma Derivatives by Type (2015-2020)
Figure 83. Sales Market Share of Blood Plasma Derivatives by Type in 2019
Figure 84. Revenue Share of Blood Plasma Derivatives by Type (2015-2020)
Figure 85. Revenue Market Share of Blood Plasma Derivatives by Type in 2019
Figure 86. Global Blood Plasma Derivatives Sales Growth by Type (2015-2020) (K MT)
Figure 87. Global Blood Plasma Derivatives Sales Market Share by Application (2015-2020)
Figure 88. Global Blood Plasma Derivatives Sales Market Share by Application in 2019
Figure 89. Global Revenue Share of Blood Plasma Derivatives by Application (2015-2020)
Figure 90. Global Revenue Share of Blood Plasma Derivatives by Application in 2020
Figure 91. Grifols Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. SK Plasma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Fusion Health Care Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Biotest AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Green Cross Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Baxter International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. LFB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Octapharma AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. CSL Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. China Biologic Products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Kedrion Biopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. BDI Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 105. Hualan Biological Engineering Total Revenue (US$ Million): 2019 Compared with 2018
Figure 106. Price Trend of Key Raw Materials
Figure 107. Manufacturing Cost Structure of Blood Plasma Derivatives
Figure 108. Manufacturing Process Analysis of Blood Plasma Derivatives
Figure 109. Blood Plasma Derivatives Industrial Chain Analysis
Figure 110. Channels of Distribution
Figure 111. Distributors Profiles
Figure 112. Porter's Five Forces Analysis
Figure 113. North America Blood Plasma Derivatives Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 114. North America Blood Plasma Derivatives Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Europe Blood Plasma Derivatives Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 116. Europe Blood Plasma Derivatives Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Latin America Blood Plasma Derivatives Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 118. Latin America Blood Plasma Derivatives Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 119. Middle East and Africa Blood Plasma Derivatives Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 120. Middle East and Africa Blood Plasma Derivatives Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 121. Asia Pacific Blood Plasma Derivatives Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 122. Asia Pacific Blood Plasma Derivatives Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs